TravelNews

[Travel News]: China administers 200 million vaccine doses domestically

TheTourAttraction.com aims to provide the latest global travel and free travel news, travel and visa policies, and flight information. We hope to provide insights into tourism market, technology and development trends with everyone by providing the latest relevant information. Despite the raging COVID-19 epidemic in 2020, we always firmly believe that mankind will overcome the disease and the tourism market will definitely recover. TheTourAttraction.com look forward to your attention and support, and witness the development of the global tourism industry with us. Looking forward to the information TheTourAttraction.com provide can help you. We will continue to follow up and obtain the latest data, and look forward to your attention and support.

The following is the [Travel News]: China administers 200 million vaccine doses domestically from [AP] recommended by TheTourAttraction.com:

China has approved five domestically produced vaccines and exported millions of doses, although some scientists believe they provide less protection than foreign vaccines.

Around 200 million doses of COVID-19 vaccine have been administered so far inside China, with an emphasis on front-line workers, university students and people living in border areas, health officials said.

China is ramping up vaccination efforts after a slow start that was due in part to the virtual elimination of domestic transmission of the coronavirus. Just two local cases were reported on Wednesday, both in the city of Ruili, which borders on Myanmar.

Just six new cases were reported on Thursday, all of them imported, while testing continued in Ruili, where China’s latest outbreak appears to have been contained.

China has approved five domestically produced vaccines and exported millions of doses, although some scientists believe they provide less protection than those by Pfizer, Moderna and AstraZeneca. The Chinese vaccines have an efficacy range of 50.7% to 79.3%, based on company data, lower than their foreign peers but still effective.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button